40
Participants
Start Date
June 1, 2024
Primary Completion Date
June 1, 2025
Study Completion Date
June 1, 2025
Cell Salvage Autotransfusion: SAME™ device
"* Intervention studied: processing of salvaged blood using the SAME™ autotransfusion device~* Population studied: 20 patients planned to undergo high-risk liver transplantation.~* Treatment group.~All perioperative measures will be performed according to international, national and in-house standards."
Cell Salvage Autotransfusion: Autolog™ device
"* Intervention studied: processing of salvaged blood using the Autolog™ (Medtronic) autotransfusion device (in-house standard device).~* Population studied: 20 patients planned to undergo high-risk liver transplantation.~* Control group~All perioperative measures will be performed according to international, national and in-house standards."
Geneva University Hospitals, Geneva
University Hospital, Geneva
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER
Eduardo Schiffer
OTHER